학술논문

Regulatory issues on pharmacovigilance in Latin American countries.
Document Type
Article
Source
Pharmaceuticals Policy & Law. 2014, Vol. 16 Issue 3/4, p289-312. 24p. 3 Charts.
Subject
*DRUG laws
*MEDICATION safety
*CLINICAL trials
*PHARMACEUTICAL industry
*PUBLIC health
Language
ISSN
1389-2827
Abstract
Pharmacovigilance is responsible for monitoring the safety of medicines in normal clinical use and during clinical trials. Legal requirements for pharmacovigilance in some Latin American countries (Argentina, Brazil, Chile, Paraguay and Uruguay) were reviewed. Disparities in the legal framework among the countries are observed being those for marketing authorization holders one of the most evident. The active rol of the universities and drug information centers for/of pharmacovilance seems to be a positive common point. Legal requirements regarding pharmacovigilance of biosimilar medicines, is still a point to be developed. [ABSTRACT FROM AUTHOR]